They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth even more.
The reason is that the disease shows no outward signs, and more than 80 percent of sufferers go undiagnosed. So while an effective cure does exist, what’s most needed is a vaccine that can prevent infection in the first place.
Friday, March 17, 2017
News Recap
Top of the news this week is a report from Cheryl Reitz who has just embarked on another Outreach Road Trip to BC's rural, remote, and First Nations communities. The report this week covers Lytton, Spences Bridge and Cache Creek. The report is very detailed and we have included a slide show. Rural/Remote/Indigenous Hepatitis C Outreach 2017 – Part 1
Other News:
Will they ever learn? Many years ago several senior...
Bengaluru: A group of Indian scientists has developed a vaccine meant to treat Hepatitis C, a virus or infection that causes liver disease and inflammation of the liver.According to the report in Times of India, the team from the Indian Institute of Science (IISc), Bengaluru, has developed a vaccine for HCV genotype 3a.The scientists said the vaccine has shown promising results in preclinical studies and is customised for the Indian population.It is said t
